Pegylated Interferon α-2b
Showing 1 - 25 of 8,883
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Lymphoma, B-Cell Trial in Guangzhou (Rituximab Biosimilar, Pegylated Interferon a-2b)
Recruiting
- Lymphoma, B-Cell
- Rituximab Biosimilar
- Pegylated Interferon α-2b
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-sen University Cancer Ce
Apr 6, 2022
Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)
Completed
- Chronic Hepatitis B
- PegIFN α- 2b
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jul 11, 2022
Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)
Recruiting
- Chronic Hepatitis B
- continuous treatment
- pulse therapy
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jul 13, 2022
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)
Recruiting
- Hematological Neoplasms
- Recurrence
- Peg interferon alfa-2b
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021
Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)
Recruiting
- Hepatitis B, Chronic
- ASC42 10mg
- +4 more
-
Guangzhou, Guangdong, ChinaNanFang Hospital of Southern Medical University
Jan 13, 2022
Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)
Recruiting
- Adult T-cell Leukemia-Lymphoma
- ATLL
- Belinostat
- +3 more
-
Miami, FloridaUniversity of Miami
Jan 24, 2022
HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)
Unknown status
- HIV
- +2 more
- Pegylated Interferon alpha 2b (peg-IFN-α2b)
- 3BNC117 + 10-1074
-
Philadelphia, Pennsylvania
- +1 more
Jun 22, 2021
Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)
Active, not recruiting
- Polycythemia Vera
- AOP2014
- +2 more
-
San Giovanni Rotondo, (FG) Puglia, Italy
- +22 more
Jan 10, 2023
Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before
Not yet recruiting
- Herpes Zoster
- Recombinant Human Interferon α-2b Gel (After the Alteration)
- Recombinant Human Interferon α-2b Gel (Before the Alteration)
- (no location specified)
Apr 7, 2023
Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)
Recruiting
- Essential Thrombocytopenia
- Recombinant Interferon Alpha
- Pegylated interferon alfa-2b
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 18, 2022
Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)
Active, not recruiting
- Malignant Melanoma
- Peginterferon alfa-2b
- +2 more
-
San Diego, California
- +2 more
Apr 1, 2022
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +2 more
- Cemiplimab-Rwlc
- PEG-IFN alfa-2a
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023
Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)
Completed
- Juvenile Pilocytic Astrocytomas
- Optic Pathway Gliomas
- Pegylated interferon alpha-2b
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jan 18, 2022
Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b
Recruiting
- Hepatocellular Carcinoma
- Anti-PD-1/PD-L1
- PEG-Interferon Alfa
-
Shanghai, ChinaZhongshan Hospital, Fudan University
Mar 28, 2022
COVID-19, Children Trial in Shanghai (Inhaled Interferon a2b, Standard of Care)
Recruiting
- COVID-19
- Children
- Inhaled Interferon α2b
- Standard of Care
-
Shanghai, ChinaChildren Hospital of Fudan University
May 18, 2022
Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)
Not yet recruiting
- Melanoma
- Recombinant human interferon α1b
- +2 more
-
Xi'an, Shaanxi, ChinaAir Force Military Medical University/ Fourth Military Medical U
Sep 13, 2022
Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)
Completed
- Hepatitis D, Chronic
- Peginterferon Lambda-1A
-
Beersheba, Israel
- +3 more
Dec 20, 2022
Coronavirus Disease 2019 Trial in Santiago (Interferon-Alpha2B, Placebo)
Completed
- Coronavirus Disease 2019
- Interferon-Alpha2B
- Placebo
-
Santiago, RM, ChileRed de Salud UC Christus
Aug 3, 2022
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)
Not yet recruiting
- Chronic Hepatitis B
- Hepalatide
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Feb 16, 2022
Chronic Hepatitis b Trial in Guangzhou (Vitamin D)
Completed
- Chronic Hepatitis b
- Vitamin D
-
Guangzhou, Guangdong, ChinaDepartment of Infectious Diseases, The Third Affliated Hospital
Mar 2, 2023
HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)
Not yet recruiting
- HPV Infection
- Human interferon alpha 2b vaginal Effervescent capsules
- (no location specified)
May 8, 2023